Showing 23,521 - 23,540 results of 109,171 for search '(( 50 ((ms decrease) OR (a decrease)) ) OR ( 10 ((we decrease) OR (nn decrease)) ))', query time: 1.28s Refine Results
  1. 23521

    QTL for reduced MA sensitivity (D2 < B6) in B6 x D2-F<sub>2</sub> mice. by Neema Yazdani (835533)

    Published 2015
    “…<p><b>(a):</b> We previously published a genome-wide a significant QTL on chromosome 11 for MA-induced locomotor activity from the same B6 x D2-F<sub>2</sub> dataset (N = 676) that was significant when the data were summed from 15–30 min and 0–30 min but not when the data were summed from 0–15 min [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005713#pgen.1005713.ref020" target="_blank">20</a>]. …”
  2. 23522

    M-MSNs@NAD<sup>+</sup> can significantly increase the intracellular NAD<sup>+</sup> and ATP levels of H<sub>2</sub>O<sub>2</sub>-treated Astrocytes. by Heyu Chen (456225)

    Published 2013
    “…<p>(A) Treatment of the cells with 1 mM H<sub>2</sub>O<sub>2</sub> led to a significant decrease in the intracellular NAD<sup>+</sup> levels of astrocytes, which was prevented by post-treatment of the cells with 50 µg/mL M-MSNs@NAD<sup>+</sup> for 3 hrs. …”
  3. 23523

    Table_2_The burden of epilepsy in the People’s Republic of China from 1990 to 2019: epidemiological trends and comparison with the global burden of epilepsy.XLSX by Yun Shu (2016445)

    Published 2023
    “…Background<p>Epilepsy is associated with a significant global burden of disease, affecting over 50 million people worldwide. …”
  4. 23524

    Table_3_The burden of epilepsy in the People’s Republic of China from 1990 to 2019: epidemiological trends and comparison with the global burden of epilepsy.DOCX by Yun Shu (2016445)

    Published 2023
    “…Background<p>Epilepsy is associated with a significant global burden of disease, affecting over 50 million people worldwide. …”
  5. 23525

    Data_Sheet_2_The burden of epilepsy in the People’s Republic of China from 1990 to 2019: epidemiological trends and comparison with the global burden of epilepsy.PDF by Yun Shu (2016445)

    Published 2023
    “…Background<p>Epilepsy is associated with a significant global burden of disease, affecting over 50 million people worldwide. …”
  6. 23526

    Comparison of autonomic stress reactivity in young healthy versus aging subjects with heart disease by Nil Z. Gurel (6681047)

    Published 2019
    “…</p><p>Results</p><p>Mental stress reduced PEP in both groups (p<0.01), although the decrease was 50% greater in the healthy group. Mean HF HRV decreased significantly in the aging group only (p = 0.01).…”
  7. 23527

    Data_Sheet_3_The burden of epilepsy in the People’s Republic of China from 1990 to 2019: epidemiological trends and comparison with the global burden of epilepsy.PDF by Yun Shu (2016445)

    Published 2023
    “…Background<p>Epilepsy is associated with a significant global burden of disease, affecting over 50 million people worldwide. …”
  8. 23528

    Table_1_The burden of epilepsy in the People’s Republic of China from 1990 to 2019: epidemiological trends and comparison with the global burden of epilepsy.XLSX by Yun Shu (2016445)

    Published 2023
    “…Background<p>Epilepsy is associated with a significant global burden of disease, affecting over 50 million people worldwide. …”
  9. 23529

    Data_Sheet_1_The burden of epilepsy in the People’s Republic of China from 1990 to 2019: epidemiological trends and comparison with the global burden of epilepsy.PDF by Yun Shu (2016445)

    Published 2023
    “…Background<p>Epilepsy is associated with a significant global burden of disease, affecting over 50 million people worldwide. …”
  10. 23530
  11. 23531

    Data_Sheet_1_Light effects on seedling growth in simulated forest canopy gaps vary across species from different successional stages.docx by Lingyan Zhou (417485)

    Published 2023
    “…Our results showed that the light condition under small canopy gaps (SG, 10–15% of full sunlight) and large canopy gaps (LG, 40–50% of full sunlight) induced greater increment of relative growth rates for seedlings from early- and mid-successional stages relative to that in late-successional stage. …”
  12. 23532
  13. 23533

    Possible roles of sestrin2 in multiple sclerosis and its relationships with clinical outcomes by Faruk Omer ODABAS (12652740)

    Published 2022
    “…Conclusions: The decreased expression of SESN2 may play a role in MS pathogenesis, and SESN2 could be used as a biomarker for MS and as immunotherapeutic agent to treat MS.…”
  14. 23534
  15. 23535
  16. 23536
  17. 23537
  18. 23538

    Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived D... by Attila Szabo (279820)

    Published 2014
    “…Here we demonstrate for the first time the immunomodulatory potential of NN-DMT and 5-MeO-DMT on human moDC functions via sigmar-1 that could be harnessed for the pharmacological treatment of autoimmune diseases and chronic inflammatory conditions of the CNS or peripheral tissues. …”
  19. 23539

    Data_Sheet_1_Proviral Quasispecies Diversity Is Not Associated With Virologic Breakthrough or CD4+ T Cell Loss in HIV-1 Elite Controllers.PDF by Suwellen S. D. de Azevedo (5369807)

    Published 2019
    “…Despite differences in proviral genetic diversity, the EC<sub>LD</sub> and EC<sub>HD</sub> subgroups displayed comparable levels of total cell-associated HIV DNA, activated CD8<sup>+</sup> T (CD38<sup>+</sup>HLA-DR<sup>+</sup>) cells and plasmatic inflammatory biomarkers (IP-10, IL-18, RANTES, PDGF-AA, and CTACK). These results indicate that the genetic diversity of the HIV-1 proviral reservoir is not a surrogate marker of residual viral replication, immune activation or inflammation, nor an accurate biomarker for the prediction of virologic breakthrough or CD4<sup>+</sup> T cells loss in EC.…”
  20. 23540